Andreea O. Lungu - Concepedia

Author

Andreea O. Lungu

National Institute of Diabetes and Digestive and Kidney Diseases

Also Known As

A LUNGU, A Lungu, A. O. Lungu, Alexandra-Elena Lungu, Andreea Lungu, Andreea O. Lungu, Lungu A., Lungu, A.

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

National Institute of Diabetes and Digestive and Kidney Diseases University of Rochester National Institutes of Health

About

Andreea O. Lungu is an author at National Institute of Diabetes and Digestive and Kidney Diseases specializing in medicine, physiology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	437
2	Health Sciences	2	2	248
3	Biochemistry	1	1	80
4	Cell Biology	1	1	109
5	Cellular Physiology	1	1	109

Andreea O. Lungu

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Ligand-Independent Activation of Vascular Endothelial Growth Factor Receptor 2 by Fluid Shear Stress Regulates Activation of Endothelial Nitric Oxide Synthase Zheng‐Gen Jin, Hiroto Ueba, Tatsuo Tanimoto, Circulation Research	2003	390
Cyclophilin A Is a Proinflammatory Cytokine that Activates Endothelial Cells Zheng‐Gen Jin, Andreea O. Lungu, Liang Xie, Arteriosclerosis Thrombosis and Vascular Biology	2004	233
The liver diseases of lipodystrophy: The long-term effect of leptin treatment Elika Safar Zadeh, Andreea O. Lungu, Elaine Cochran, Journal of Hepatology Metabolic SyndromeLeptin TreatmentLong-term EffectHepatologyMedicine	2013	165
Treatment of Type B Insulin Resistance: A Novel Approach to Reduce Insulin Receptor Autoantibodies Rana Malek, Angeline Y. Chong, Beatrice Lupsa, The Journal of Clinical Endocrinology & Metabolism	2010	110
Sphingosine 1-Phosphate Transactivates the Platelet-Derived Growth Factor β Receptor and Epidermal Growth Factor Receptor in Vascular Smooth Muscle Cells Tatsuo Tanimoto, Andreea O. Lungu, Bradford C. Berk Circulation Research InflammationBioactive LipidMolecular PhysiologySignal TransductionAngiogenesis	2004	109
Cardiomyopathy in Congenital and Acquired Generalized Lipodystrophy Beatrice Lupsa, Vandana Sachdev, Andreea O. Lungu, Medicine ObesityMetabolic SyndromeCardiomyopathyHeart FailureCardiovascular Disease	2010	83
Cyclosporin A Inhibits Flow-mediated Activation of Endothelial Nitric-oxide Synthase by Altering Cholesterol Content in Caveolae Andreea O. Lungu, Zheng‐Gen Jin, Hideyuki Yamawaki, Journal of Biological Chemistry Vascular DiseaseImmunologyOxidative StressBlood FlowInflammation	2004	80
Insulin Resistance Is a Sufficient Basis for Hyperandrogenism in Lipodystrophic Women with Polycystic Ovarian Syndrome Andreea O. Lungu, Elika Safar Zadeh, Anne Goodling, The Journal of Clinical Endocrinology & Metabolism	2011	61
The Role of Proinsulin and Insulin in the Diagnosis of Insulinoma: A Critical Evaluation of the Endocrine Society Clinical Practice Guideline Jean‐Marc Guettier, Andreea O. Lungu, Anne Goodling, The Journal of Clinical Endocrinology & Metabolism	2013	45
Bone Mineral Content in Patients With Congenital Generalized Lipodystrophy Is Unaffected by Metreleptin Replacement Therapy John D. Christensen, Andreea O. Lungu, Elaine Cochran, The Journal of Clinical Endocrinology & Metabolism	2014	43

Page 1